$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

The role of glycation in the pathogenesis of aging and its prevention through herbal products and physical exercise 원문보기

Journal of exercise nutrition&biochemistry, v.21 no.3, 2017년, pp.55 - 61  

Kim, Chan-Sik (Korean Medicine Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon Republic of Korea) ,  Park, Sok (Department of Sports Leadership, Kwangwoon University, Seoul Republic of Korea) ,  Kim, Junghyun (Department of Oral Pathology, School of Dentistry, Chonbuk National University, Jeonju Republic of Korea)

Abstract AI-Helper 아이콘AI-Helper

[Purpose]Advanced glycation end products (AGEs) are non-enzymatic modifications of proteins or lipids after exposure to sugars. In this review, the glycation process and AGEs are introduced, and the harmful effects of AGEs in the aging process are discussed.[Methods]Results from human and animal stu...

주제어

참고문헌 (75)

  1. 1 Harman D. The aging process. Proc Natl Acad Sci U S A. 1981; 78: 7124-8. Harman D The aging process Proc Natl Acad Sci U S A 1981 78 7124 8 6947277 

  2. 2 Gladyshev VN. On the cause of aging and control of lifespan: heterogeneity leads to inevitable damage accumulation, causing aging; control of damage composition and rate of accumulation define lifespan. Bioessays. 2012; 34: 925-9. Gladyshev VN On the cause of aging and control of lifespan: heterogeneity leads to inevitable damage accumulation, causing aging; control of damage composition and rate of accumulation define lifespan Bioessays 2012 34 925 9 22915358 

  3. 3 Gladyshev VN. The origin of aging: imperfectness-driven non-random damage defines the aging process and control of lifespan. Trends Genet. 2013; 29: 506-12. Gladyshev VN The origin of aging: imperfectness-driven non-random damage defines the aging process and control of lifespan Trends Genet 2013 29 506 12 10.1016/j.tig.2013.05.004 23769208 

  4. 4 Maillard L. Action des acides amines sur les sucres; formation des melanoidines par voie methodique. C R Acad Sci. 1912; 154: 66-8. Maillard L Action des acides amines sur les sucres; formation des melanoidines par voie methodique C R Acad Sci 1912 154 66 8 

  5. 5 Sell DR, Monnier VM. Molecular basis of arterial stiffening: role of glycation - a mini-review. Gerontology. 2012; 58: 227-37. Sell DR Monnier VM Molecular basis of arterial stiffening: role of glycation - a mini-review Gerontology 2012 58 227 37 10.1159/000334668 22222677 

  6. 6 Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci. 2010; 65: 963-75. Semba RD Nicklett EJ Ferrucci L Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci 2010 65 963 75 20478906 

  7. 7 Nguyen HP, Katta R. Sugar Sag: Glycation and the Role of Diet in Aging Skin. Skin Therapy Lett. 2015; 20: 1-5. Nguyen HP Katta R Sugar Sag: Glycation and the Role of Diet in Aging Skin Skin Therapy Lett 2015 20 1 5 

  8. 8 Ahmed N, Thornalley PJ. Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring. Biochem Soc Trans. 2003; 31: 1417-22. Ahmed N Thornalley PJ Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring Biochem Soc Trans 2003 31 1417 22 10.1042/bst0311417 14641078 

  9. 9 Suji G, Sivakami S. Glucose, glycation and aging. Biogerontology. 2004; 5: 365-73. Suji G Sivakami S Glucose, glycation and aging Biogerontology 2004 5 365 73 10.1007/s10522-004-3189-0 15609100 

  10. 10 Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med. 1995; 46: 223-34. Brownlee M Advanced protein glycosylation in diabetes and aging Annu Rev Med 1995 46 223 34 7598459 

  11. 11 Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991; 40: 405-12. Baynes JW Role of oxidative stress in development of complications in diabetes Diabetes 1991 40 405 12 10.2337/diabetes.40.4.405 2010041 

  12. 12 Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, et al. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nat Med. 1995; 1: 693-9. Yan SD Yan SF Chen X Fu J Chen M Kuppusamy P et al. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide Nat Med 1995 1 693 9 7585153 

  13. 13 Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010; 107: 1058-70. Giacco F Brownlee M Oxidative stress and diabetic complications Circ Res 2010 107 1058 70 10.1161/circresaha.110.223545 21030723 

  14. 14 Peng X, Ma J, Chen F, Wang M. Naturally occurring inhibitors against the formation of advanced glycation end-products. Food Funct. 2011; 2: 289-301. Peng X Ma J Chen F Wang M Naturally occurring inhibitors against the formation of advanced glycation end-products Food Funct 2011 2 289 301 10.1039/c1fo10034c 21779567 

  15. 15 Sadowska-Bartosz I, Bartosz G. Effect of glycation inhibitors on aging and age-related diseases. Mech Ageing Dev. 2016; 160: 1-18. Sadowska-Bartosz I Bartosz G Effect of glycation inhibitors on aging and age-related diseases Mech Ageing Dev 2016 160 1 18 10.1016/j.mad.2016.09.006 27671971 

  16. 16 Kim JW, No JK, Ikeno Y, Yu BP, Choi JS, Yokozawa T, et al. Age-related changes in redox status of rat serum. Arch Gerontol Geriatr. 2002; 34: 9-17. Kim JW No JK Ikeno Y Yu BP Choi JS Yokozawa T et al. Age-related changes in redox status of rat serum Arch Gerontol Geriatr 2002 34 9 17 10.1016/s0167-4943(01)00178-9 14764306 

  17. 17 Radak Z, Chung HY, Naito H, Takahashi R, Jung KJ, Kim HJ, et al. Age-associated increase in oxidative stress and nuclear factor kappaB activation are attenuated in rat liver by regular exercise. FASEB J. 2004; 18: 749-50. Radak Z Chung HY Naito H Takahashi R Jung KJ Kim HJ et al. Age-associated increase in oxidative stress and nuclear factor kappaB activation are attenuated in rat liver by regular exercise FASEB J 2004 18 749 50 14766800 

  18. 18 Asghar M, George L, Lokhandwala MF. Exercise decreases oxidative stress and inflammation and restores renal dopamine D1 receptor function in old rats. Am J Physiol Renal Physiol. 2007; 293: F914-9. Asghar M George L Lokhandwala MF Exercise decreases oxidative stress and inflammation and restores renal dopamine D1 receptor function in old rats Am J Physiol Renal Physiol 2007 293 F914 9 10.1152/ajprenal.00272.2007 17634393 

  19. 19 Navarro A, Gomez C, Lopez-Cepero JM, Boveris A. Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. Am J Physiol Regul Integr Comp Physiol. 2004; 286: R505-11. Navarro A Gomez C Lopez-Cepero JM Boveris A Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer Am J Physiol Regul Integr Comp Physiol 2004 286 R505 11 10.1152/ajpregu.00208.2003 14615275 

  20. 20 Gomez-Cabrera MC, Domenech E, Vina J. Moderate exercise is an antioxidant: upregulation of antioxidant genes by training. Free Radic Biol Med. 2008; 44: 126-31. Gomez-Cabrera MC Domenech E Vina J Moderate exercise is an antioxidant: upregulation of antioxidant genes by training Free Radic Biol Med 2008 44 126 31 10.1016/j.freeradbiomed.2007.02.001 18191748 

  21. 21 Boor P, Celec P, Behuliak M, Grancic P, Kebis A, Kukan M, et al. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats. Metabolism. 2009; 58: 1669-77. Boor P Celec P Behuliak M Grancic P Kebis A Kukan M et al. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats Metabolism 2009 58 1669 77 10.1016/j.metabol.2009.05.025 19608208 

  22. 22 Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001; 286: 1218-27. Boule NG Haddad E Kenny GP Wells GA Sigal RJ Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials JAMA 2001 286 1218 27 11559268 

  23. 23 Oudes AJ, Herr CM, Olsen Y, Fleming JE. Age-dependent accumulation of advanced glycation end-products in adult Drosophila melanogaster. Mech Ageing Dev. 1998; 100: 221-9. Oudes AJ Herr CM Olsen Y Fleming JE Age-dependent accumulation of advanced glycation end-products in adult Drosophila melanogaster Mech Ageing Dev 1998 100 221 9 10.1016/s0047-6374(97)00146-2 9578111 

  24. 24 Schlotterer A, Kukudov G, Bozorgmehr F, Hutter H, Du X, Oikonomou D, et al. C. elegans as model for the study of high glucose- mediated life span reduction. Diabetes. 2009; 58: 2450-6. Schlotterer A Kukudov G Bozorgmehr F Hutter H Du X Oikonomou D et al. C. elegans as model for the study of high glucose-mediated life span reduction Diabetes 2009 58 2450 6 10.2337/db09-0567 19675139 

  25. 25 Ott C, Jacobs K, Haucke E, Navarrete Santos A, Grune T, Simm A. Role of advanced glycation end products in cellular signaling. Redox Biol. 2014; 2: 411-29. Ott C Jacobs K Haucke E Navarrete Santos A Grune T Simm A Role of advanced glycation end products in cellular signaling Redox Biol 2014 2 411 29 10.1016/j.redox.2013.12.016 24624331 

  26. 26 Schalkwijk CG, Miyata T. Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics. Amino Acids. 2012; 42: 1193-204. Schalkwijk CG Miyata T Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics Amino Acids 2012 42 1193 204 10.1007/s00726-010-0779-9 20960212 

  27. 27 Dalal M, Sun K, Cappola AR, Ferrucci L, Crasto C, Fried LP, et al. Relationship of serum fibroblast growth factor 23 with cardiovascular disease in older community-dwelling women. Eur J Endocrinol. 2011; 165: 797-803. Dalal M Sun K Cappola AR Ferrucci L Crasto C Fried LP et al. Relationship of serum fibroblast growth factor 23 with cardiovascular disease in older community-dwelling women Eur J Endocrinol 2011 165 797 803 10.1530/eje-11-0577 21873490 

  28. 28 Pageon H, Zucchi H, Rousset F, Monnier VM, Asselineau D. Skin aging by glycation: lessons from the reconstructed skin model. Clin Chem Lab Med. 2014; 52: 169-74. Pageon H Zucchi H Rousset F Monnier VM Asselineau D Skin aging by glycation: lessons from the reconstructed skin model Clin Chem Lab Med 2014 52 169 74 10.1515/cclm-2013-0091 23770560 

  29. 29 Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res. 2001; 56: 1-21. Ulrich P Cerami A Protein glycation, diabetes, and aging Recent Prog Horm Res 2001 56 1 21 10.1210/rp.56.1.1 11237208 

  30. 30 Yao D, Taguchi T, Matsumura T, Pestell R, Edelstein D, Giardino I, et al. High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem. 2007; 282: 31038-45. Yao D Taguchi T Matsumura T Pestell R Edelstein D Giardino I et al. High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A J Biol Chem 2007 282 31038 45 10.1074/jbc.m704703200 17670746 

  31. 31 Wu L, Juurlink BH. Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension. 2002; 39: 809-14. Wu L Juurlink BH Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells Hypertension 2002 39 809 14 10.1161/hy0302.105207 11897769 

  32. 32 Bakala H, Ladouce R, Baraibar MA, Friguet B. Differential expression and glycative damage affect specific mitochondrial proteins with aging in rat liver. Biochim Biophys Acta. 2013; 1832: 2057-67. Bakala H Ladouce R Baraibar MA Friguet B Differential expression and glycative damage affect specific mitochondrial proteins with aging in rat liver Biochim Biophys Acta 2013 1832 2057 67 10.1016/j.bbadis.2013.07.015 23906978 

  33. 33 Reeg S, Grune T. Protein Oxidation in Aging: Does It Play a Role in Aging Progression? Antioxid Redox Signal. 2015; 23: 239-55. Reeg S Grune T Protein Oxidation in Aging: Does It Play a Role in Aging Progression? Antioxid Redox Signal 2015 23 239 55 10.1089/ars.2014.6062 25178482 

  34. 34 Boulanger E, Wautier MP, Wautier JL, Boval B, Panis Y, Wernert N, et al. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int. 2002; 61: 148-56. Boulanger E Wautier MP Wautier JL Boval B Panis Y Wernert N et al. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression Kidney Int 2002 61 148 56 10.1046/j.1523-1755.2002.00115.x 11786095 

  35. 35 Roca F, Grossin N, Chassagne P, Puisieux F, Boulanger E. Glycation: the angiogenic paradox in aging and age-related disorders and diseases. Ageing Res Rev. 2014; 15: 146-60. Roca F Grossin N Chassagne P Puisieux F Boulanger E Glycation: the angiogenic paradox in aging and age-related disorders and diseases Ageing Res Rev 2014 15 146 60 10.1016/j.arr.2014.03.009 24742501 

  36. 36 Omsland TK, Bangstad HJ, Berg TJ, Kolset SO.Advanced glycation end products and hyperglycaemia. Tidsskr Nor Laegeforen. 2006; 126: 155-8. Omsland TK Bangstad HJ Berg TJ Kolset SO Advanced glycation end products and hyperglycaemia Tidsskr Nor Laegeforen 2006 126 155 8 16415936 

  37. 37 Grossin N, Auger F, Niquet-Leridon C, Durieux N, Montaigne D, Schmidt AM, et al. Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice. Mol Nutr Food Res. 2015; 59: 927-38. Grossin N Auger F Niquet-Leridon C Durieux N Montaigne D Schmidt AM et al. Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice Mol Nutr Food Res 2015 59 927 38 10.1002/mnfr.201400643 25655894 

  38. 38 Stopper H, Schinzel R, Sebekova K, Heidland A. Genotoxicity of advanced glycation end products in mammalian cells. Cancer Lett. 2003; 190: 151-6. Stopper H Schinzel R Sebekova K Heidland A Genotoxicity of advanced glycation end products in mammalian cells Cancer Lett 2003 190 151 6 10.1016/s0304-3835(02)00626-2 12565169 

  39. 39 Peppa M, Brem H, Ehrlich P, Zhang JG, Cai W, Li Z, et al. Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes. 2003; 52: 2805-13. Peppa M Brem H Ehrlich P Zhang JG Cai W Li Z et al. Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice Diabetes 2003 52 2805 13 10.2337/diabetes.52.11.2805 14578300 

  40. 40 Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, He C, et al. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J Am Soc Nephrol. 2003; 14: 728-31. Uribarri J Peppa M Cai W Goldberg T Lu M He C et al. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients J Am Soc Nephrol 2003 14 728 31 10.1097/01.asn.0000051593.41395.b9 12595509 

  41. 41 Huebschmann AG, Regensteiner JG, Vlassara H, Reusch JE. Diabetes and advanced glycoxidation end products. Diabetes Care. 2006; 29: 1420-32. Huebschmann AG Regensteiner JG Vlassara H Reusch JE Diabetes and advanced glycoxidation end products Diabetes Care 2006 29 1420 32 10.2337/dc05-2096 16732039 

  42. 42 Kim J, Kim CS, Moon MK, Kim JS. Epicatechin breaks preformed glycated serum albumin and reverses the retinal accumulation of advanced glycation end products. Eur J Pharmacol. 2015; 748: 108-14. Kim J Kim CS Moon MK Kim JS Epicatechin breaks preformed glycated serum albumin and reverses the retinal accumulation of advanced glycation end products Eur J Pharmacol 2015 748 108 14 10.1016/j.ejphar.2014.12.010 25530268 

  43. 43 Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science. 1986; 232: 1629-32. Brownlee M Vlassara H Kooney A Ulrich P Cerami A Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking Science 1986 232 1629 32 10.1126/science.3487117 3487117 

  44. 44 Lo TW, Selwood T, Thornalley PJ. The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins. Biochem Pharmacol. 1994; 48: 1865-70. Lo TW Selwood T Thornalley PJ The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins Biochem Pharmacol 1994 48 1865 70 10.1016/0006-2952(94)90584-3 7986197 

  45. 45 Thornalley PJ, Yurek-George A, Argirov OK. Kinetics and mechanism of the reaction of aminoguanidine with the alpha-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions. Biochem Pharmacol. 2000; 60: 55-65. Thornalley PJ Yurek-George A Argirov OK Kinetics and mechanism of the reaction of aminoguanidine with the alpha-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions Biochem Pharmacol 2000 60 55 65 10807945 

  46. 46 Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys. 2003; 419: 31-40. Thornalley PJ Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts Arch Biochem Biophys 2003 419 31 40 10.1016/j.abb.2003.08.013 14568006 

  47. 47 Suji G, Sivakami S. DNA damage by free radical production by aminoguanidine. Ann N Y Acad Sci. 2006; 1067: 191-9. Suji G Sivakami S DNA damage by free radical production by aminoguanidine Ann N Y Acad Sci 2006 1067 191 9 10.1196/annals.1354.023 16803985 

  48. 48 Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, et al. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes. 1993; 42: 221-32. Tilton RG Chang K Hasan KS Smith SR Petrash JM Misko TP et al. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation Diabetes 1993 42 221 32 10.2337/diab.42.2.221 7678825 

  49. 49 Turgut F, Bolton WK. Potential new therapeutic agents for diabetic kidney disease. Am J Kidney Dis. 2010; 55: 928-40. Turgut F Bolton WK Potential new therapeutic agents for diabetic kidney disease Am J Kidney Dis 2010 55 928 40 10.1053/j.ajkd.2009.11.021 20138415 

  50. 50 Wolffenbuttel BH, Boulanger CM, Crijns FR, Huijberts MS, Poitevin P, Swennen GN, et al. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc Natl Acad Sci U S A. 1998; 95: 4630-4. Wolffenbuttel BH Boulanger CM Crijns FR Huijberts MS Poitevin P Swennen GN et al. Breakers of advanced glycation end products restore large artery properties in experimental diabetes Proc Natl Acad Sci U S A 1998 95 4630 4 10.1073/pnas.95.8.4630 9539789 

  51. 51 Sugiyama S, Miyata T, Ueda Y, Tanaka H, Maeda K, Kawashima S, et al. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J Am Soc Nephrol. 1998; 9: 1681-8. Sugiyama S Miyata T Ueda Y Tanaka H Maeda K Kawashima S et al. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product J Am Soc Nephrol 1998 9 1681 8 9727377 

  52. 52 Lee HS, Jung SH, Yun BS, Lee KW. Isolation of chebulic acid from Terminalia chebula Retz. and its antioxidant effect in isolated rat hepatocytes. Arch Toxicol. 2007; 81: 211-8. Lee HS Jung SH Yun BS Lee KW Isolation of chebulic acid from Terminalia chebula Retz. and its antioxidant effect in isolated rat hepatocytes Arch Toxicol 2007 81 211 8 10.1007/s00204-006-0139-4 16932919 

  53. 53 Lv L, Shao X, Chen H, Ho CT, Sang S. Genistein inhibits advanced glycation end product formation by trapping methylglyoxal. Chem Res Toxicol. 2011; 24: 579-86. Lv L Shao X Chen H Ho CT Sang S Genistein inhibits advanced glycation end product formation by trapping methylglyoxal Chem Res Toxicol 2011 24 579 86 10.1021/tx100457h 21344933 

  54. 54 Bournival J, Francoeur MA, Renaud J, Martinoli MG. Quercetin and sesamin protect neuronal PC12 cells from high-glucose-induced oxidation, nitrosative stress, and apoptosis. Rejuvenation Res. 2012; 15: 322-33. Bournival J Francoeur MA Renaud J Martinoli MG Quercetin and sesamin protect neuronal PC12 cells from high-glucose-induced oxidation, nitrosative stress, and apoptosis Rejuvenation Res 2012 15 322 33 10.1089/rej.2011.1242 22524206 

  55. 55 Sadowska-Bartosz I, Galiniak S, Bartosz G. Kinetics of glycoxidation of bovine serum albumin by methylglyoxal and glyoxal and its prevention by various compounds. Molecules. 2014; 19: 4880-96. Sadowska-Bartosz I Galiniak S Bartosz G Kinetics of glycoxidation of bovine serum albumin by methylglyoxal and glyoxal and its prevention by various compounds Molecules 2014 19 4880 96 10.3390/molecules19044880 24747646 

  56. 56 Xie Y, Chen X. Structures required of polyphenols for inhibiting advanced glycation end products formation. Curr Drug Metab. 2013; 14: 414-31. Xie Y Chen X Structures required of polyphenols for inhibiting advanced glycation end products formation Curr Drug Metab 2013 14 414 31 10.2174/1389200211314040005 23330933 

  57. 57 Baba S, Osakabe N, Natsume M, Muto Y, Takizawa T, Terao J. In vivo comparison of the bioavailability of (+)-catechin, (-)-epicatechin and their mixture in orally administered rats. J Nutr. 2001; 131: 2885-91. Baba S Osakabe N Natsume M Muto Y Takizawa T Terao J In vivo comparison of the bioavailability of (+)-catechin, (-)-epicatechin and their mixture in orally administered rats J Nutr 2001 131 2885 91 11694613 

  58. 58 Wang L, Tian W, Uwais Z, Li G, Li H, Guan R, et al. AGE-breaker ALT-711 plus insulin could restore erectile function in streptozocin-induced type 1 diabetic rats. J Sex Med. 2014; 11: 1452-62. Wang L Tian W Uwais Z Li G Li H Guan R et al. AGE-breaker ALT-711 plus insulin could restore erectile function in streptozocin-induced type 1 diabetic rats J Sex Med 2014 11 1452 62 10.1111/jsm.12533 24766706 

  59. 59 Panteleeva IG, Rogozkin VA.Effect of physical load on serum protein glycation in rats with induced diabetes. Ross Fiziol Zh Im I M Sechenova. 2001; 87: 1202-7. Panteleeva IG Rogozkin VA Effect of physical load on serum protein glycation in rats with induced diabetes Ross Fiziol Zh Im I M Sechenova 2001 87 1202 7 11763533 

  60. 60 Gu Q, Wang B, Zhang XF, Ma YP, Liu JD, Wang XZ. Contribution of receptor for advanced glycation end products to vasculature-protecting effects of exercise training in aged rats. Eur J Pharmacol. 2014; 741: 186-94. Gu Q Wang B Zhang XF Ma YP Liu JD Wang XZ Contribution of receptor for advanced glycation end products to vasculature-protecting effects of exercise training in aged rats Eur J Pharmacol 2014 741 186 94 10.1016/j.ejphar.2014.08.017 25160740 

  61. 61 Wright KJ, Thomas MM, Betik AC, Belke D, Hepple RT. Exercise training initiated in late middle age attenuates cardiac fibrosis and advanced glycation end-product accumulation in senescent rats. Exp Gerontol. 2014; 50: 9-18. Wright KJ Thomas MM Betik AC Belke D Hepple RT Exercise training initiated in late middle age attenuates cardiac fibrosis and advanced glycation end-product accumulation in senescent rats Exp Gerontol 2014 50 9 18 10.1016/j.exger.2013.11.006 24280067 

  62. 62 Couppe C, Svensson RB, Grosset JF, Kovanen V, Nielsen RH, Olsen MR, et al. Life-long endurance running is associated with reduced glycation and mechanical stress in connective tissue. Age (Dordr). 2014; 36: 9665. Couppe C Svensson RB Grosset JF Kovanen V Nielsen RH Olsen MR et al. Life-long endurance running is associated with reduced glycation and mechanical stress in connective tissue Age (Dordr) 2014 36 9665 24997017 

  63. 63 Kim CS, Park S, Chun Y, Song W, Kim HJ, Kim J. Treadmill Exercise Attenuates Retinal Oxidative Stress in Naturally-Aged Mice: An Immunohistochemical Study. Int J Mol Sci. 2015; 16: 21008-20. Kim CS Park S Chun Y Song W Kim HJ Kim J Treadmill Exercise Attenuates Retinal Oxidative Stress in Naturally-Aged Mice: An Immunohistochemical Study Int J Mol Sci 2015 16 21008 20 10.3390/ijms160921008 26404251 

  64. 64 Pechter U, Maaroos J, Mesikepp S, Veraksits A, Ots M. Regular low-intensity aquatic exercise improves cardio-respiratory functional capacity and reduces proteinuria in chronic renal failure patients. Nephrol Dial Transplant. 2003; 18: 624-5. Pechter U Maaroos J Mesikepp S Veraksits A Ots M Regular low-intensity aquatic exercise improves cardio-respiratory functional capacity and reduces proteinuria in chronic renal failure patients Nephrol Dial Transplant 2003 18 624 5 10.1093/ndt/18.3.624 12584298 

  65. 65 Moinuddin I, Leehey DJ. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease. Adv Chronic Kidney Dis. 2008; 15: 83-96. Moinuddin I Leehey DJ A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease Adv Chronic Kidney Dis 2008 15 83 96 10.1053/j.ackd.2007.10.004 18155113 

  66. 66 Coelho BL, Rocha LG, Scarabelot KS, Scheffer DL, Ronsani MM, Silveira PC, et al. Physical exercise prevents the exacerbation of oxidative stress parameters in chronic kidney disease. J Ren Nutr. 2010; 20: 169-75. Coelho BL Rocha LG Scarabelot KS Scheffer DL Ronsani MM Silveira PC et al. Physical exercise prevents the exacerbation of oxidative stress parameters in chronic kidney disease J Ren Nutr 2010 20 169 75 10.1053/j.jrn.2009.10.007 20199876 

  67. 67 Turk Z, Misur I, Turk N, Benko B. Rat tissue collagen modified by advanced glycation: correlation with duration of diabetes and glycemic control. Clin Chem Lab Med. 1999; 37: 813-20. Turk Z Misur I Turk N Benko B Rat tissue collagen modified by advanced glycation: correlation with duration of diabetes and glycemic control Clin Chem Lab Med 1999 37 813 20 10.1515/cclm.1999.122 10536930 

  68. 68 Hu S, He W, Liu Z, Xu H, Ma G. The accumulation of the glycoxidation product N(epsilon)-carboxymethyllysine in cardiac tissues with age, diabetes mellitus and coronary heart disease. Tohoku J Exp Med. 2013; 230: 25-32. Hu S He W Liu Z Xu H Ma G The accumulation of the glycoxidation product N(epsilon)-carboxymethyllysine in cardiac tissues with age, diabetes mellitus and coronary heart disease Tohoku J Exp Med 2013 230 25 32 23676456 

  69. 69 Albon J, Karwatowski WS, Avery N, Easty DL, Duance VC. Changes in the collagenous matrix of the aging human lamina cribrosa. Br J Ophthalmol. 1995; 79: 368-75. Albon J Karwatowski WS Avery N Easty DL Duance VC Changes in the collagenous matrix of the aging human lamina cribrosa Br J Ophthalmol 1995 79 368 75 10.1136/bjo.79.4.368 7742286 

  70. 70 Bellmunt MJ, Portero M, Pamplona R, Cosso L, Odetti P, Prat J. Evidence for the Maillard reaction in rat lung collagen and its relationship with solubility and age. Biochim Biophys Acta. 1995; 1272: 53-60. Bellmunt MJ Portero M Pamplona R Cosso L Odetti P Prat J Evidence for the Maillard reaction in rat lung collagen and its relationship with solubility and age Biochim Biophys Acta 1995 1272 53 60 10.1016/0925-4439(95)00069-g 7662720 

  71. 71 Nowotny K, Grune T. Degradation of oxidized and glycoxidized collagen: role of collagen cross-linking. Arch Biochem Biophys. 2014; 542: 56-64. Nowotny K Grune T Degradation of oxidized and glycoxidized collagen: role of collagen cross-linking Arch Biochem Biophys 2014 542 56 64 10.1016/j.abb.2013.12.007 24361253 

  72. 72 van Deemter M, Ponsioen TL, Bank RA, Snabel JM, van der Worp RJ, Hooymans JM, et al. Pentosidine accumulates in the aging vitreous body: a gender effect. Exp Eye Res. 2009; 88: 1043-50. van Deemter M Ponsioen TL Bank RA Snabel JM van der Worp RJ Hooymans JM et al. Pentosidine accumulates in the aging vitreous body: a gender effect Exp Eye Res 2009 88 1043 50 10.1016/j.exer.2009.01.004 19450456 

  73. 73 Matsumine M, Shibata N, Ishitani K, Kobayashi M, Ohta H. Pentosidine accumulation in human oocytes and their correlation to age-related apoptosis. Acta Histochem Cytochem. 2008; 41: 97-104. Matsumine M Shibata N Ishitani K Kobayashi M Ohta H Pentosidine accumulation in human oocytes and their correlation to age-related apoptosis Acta Histochem Cytochem 2008 41 97 104 10.1267/ahc.08014 18787640 

  74. 74 Sivan SS, Tsitron E, Wachtel E, Roughley P, Sakkee N, van der Ham F, et al. Age-related accumulation of pentosidine in aggrecan and collagen from normal and degenerate human intervertebral discs. Biochem J. 2006; 399: 29-35. Sivan SS Tsitron E Wachtel E Roughley P Sakkee N van der Ham F et al. Age-related accumulation of pentosidine in aggrecan and collagen from normal and degenerate human intervertebral discs Biochem J 2006 399 29 35 10.1042/bj20060579 16787390 

  75. 75 Verzijl N, DeGroot J, Oldehinkel E, Bank RA, Thorpe SR, Baynes JW, et al. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J. 2000; 350 Pt 2: 381-7. Verzijl N DeGroot J Oldehinkel E Bank RA Thorpe SR Baynes JW et al. Age-related accumulation of Maillard reaction products in human articular cartilage collagen Biochem J 2000 350 Pt 2 381 7 10.1042/0264-6021:3500381 10947951 

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로